Hasil Pencarian - Xavier Jaumont

  • Menampilkan 1 - 6 hasil dari 6
Perbaiki Hasil
  1. 1
    Targeting immunoglobulin E in atopic dermatitis: A review of the existing evidence

    Targeting immunoglobulin E in atopic dermatitis: A review of the existing evidence oleh Andreas Wollenberg, Simon Francis Thomsen, Jean-Philippe Lacour, Xavier Jaumont, Slawomir Lazarewicz

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results

    Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results oleh Marcus Maurer, Ana Giménez-Arnau, Luis Felipe Ensina, Chia-Yu Chu, Xavier Jaumont, Paolo Tassinari

    Diterbitkan 2020-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Ligelizumab treatment for severe asthma: learnings from the clinical development programme

    Ligelizumab treatment for severe asthma: learnings from the clinical development programme oleh Jordis Trischler, Ivan Bottoli, Reinhold Janocha, Christoph Heusser, Xavier Jaumont, Phil Lowe, Aurelie Gautier, Abhijit Pethe, Ralph Woessner, Hans‐Günter Zerwes, Stefan Zielen

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Long-term effectiveness and safety of omalizumab in pediatric and adult patients with moderate-to-severe inadequately controlled allergic asthma

    Long-term effectiveness and safety of omalizumab in pediatric and adult patients with moderate-to-severe inadequately controlled allergic asthma oleh Nicola A. Hanania, MD, Robert Niven, MD, Pascal Chanez, MD, PhD, Deschildre Antoine, MD, PhD, Pascal Pfister, MD, Lorena Garcia Conde, MD, Xavier Jaumont, MD

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Omalizumab for the treatment of patients with severe allergic asthma with immunoglobulin E levels above >1500 IU/mL

    Omalizumab for the treatment of patients with severe allergic asthma with immunoglobulin E levels above >1500 IU/mL oleh Francesco Menzella, MD, Jocelyne Just, MD, PhD, HDR, Inessa Schwab Sauerbeck, PhD, Claudia Mailaender, PhD, Fabiana Saccheri, PhD, Celine Thonnelier, Pharm D, Xavier Jaumont, MD, Laurence Mala, Pharm D

    Diterbitkan 2023-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab

    Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab oleh Serge Doan, MD, Nikolaos G. Papadopoulos, MD, Jason K. Lee, MD, Salvatore Leonardi, MD, Sara Manti, MD, Susanne Lau, Carmen Rondon, Vibha Sharma, MD, Uwe Pleyer, MD, Xavier Jaumont, MD, Slawomir B. Lazarewicz, MD

    Diterbitkan 2023-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: